ArticleDiabetes, obesity & metabolism2021

Treatment persistence in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists in clinical practice in Sweden.

Ann-Marie Svensson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.